Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Insulin (IN-105) in Type 1 Diabetes Patients

NCT01035801 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
20
Enrollment
INDUSTRY
Sponsor class

Stopped This study was temporarily paused due to an unanticipated bioanalytical issue.

Conditions

Interventions

Sponsor

Biocon Limited